Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

About one in three people will develop shingles in their lifetime and nearly all adults aged 50 years and older carry the inactive virus that causes it. But the the risk of develo ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

As of now, when it comes to protection against prevalent diseases, Dr Gagandeep Kang, a renowned virologist, points that our ...

More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older.

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

Most paediatricians recommend vaccinations for children. It is absolutely wrong to leave it up to fate to protect them from ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

Mpox transmits through close physical contact, including sexual contact. There is no evidence that it spreads easily through ...